[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47527"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Etomidate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47527",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C245",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C245",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C245",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C245",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47528"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Etonogestrel"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47528",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A synthetic form of the naturally occurring female sex hormone progesterone. Etonogestrel binds to the cytoplasmic progesterone receptors in the reproductive system and subsequently activates progesterone receptor mediated gene expression. As a result of the negative feedback mechanism, luteinizing hormone (LH) release is inhibited, which leads to an inhibition of ovulation and an alteration in the cervical mucus and endometrium."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C776",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C776",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C776",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C776",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47529"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ezetimibe"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47529",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush border of the small intestine and inhibits the intestinal absorption of cholesterol and related phytosterols. As a result, ezetimibe causes a decrease in the level of blood cholesterol or an increase in the clearance of cholesterol from the bloodstream. Overall, the following effects observed are a reduction of hepatic cholesterol stores and a reduction of total cholesterol, LDL cholesterol, and other triglycerides in the blood."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29703",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29703",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29703",
      "http://purl.obolibrary.org/obo/NCIT_C78276",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29703",
      "http://purl.obolibrary.org/obo/NCIT_C78276",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C4753"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "B-Cell Prolymphocytic Leukemia"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C4753",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A malignant B-cell lymphoproliferative process affecting the blood, bone marrow, and spleen.  The B-prolymphocytes are medium-sized, round lymphoid cells with prominent nucleoli.  The B-prolymphocytes must exceed 55% of lymphoid cells in the blood.  Cases of transformed chronic lymphocytic leukemia (CLL) and CLL with increased prolymphocytes are excluded.  The prognosis is poor.  (WHO, 2001)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C188021",
      "http://purl.obolibrary.org/obo/NCIT_C27910",
      "http://purl.obolibrary.org/obo/NCIT_C3181"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C188021",
      "http://purl.obolibrary.org/obo/NCIT_C27910",
      "http://purl.obolibrary.org/obo/NCIT_C3181"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C188021",
      "http://purl.obolibrary.org/obo/NCIT_C27907",
      "http://purl.obolibrary.org/obo/NCIT_C179052",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C27910",
      "http://purl.obolibrary.org/obo/NCIT_C3181",
      "http://purl.obolibrary.org/obo/NCIT_C3483",
      "http://purl.obolibrary.org/obo/NCIT_C3161",
      "http://purl.obolibrary.org/obo/NCIT_C7539"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C188021",
      "http://purl.obolibrary.org/obo/NCIT_C27907",
      "http://purl.obolibrary.org/obo/NCIT_C179052",
      "http://purl.obolibrary.org/obo/NCIT_C9308",
      "http://purl.obolibrary.org/obo/NCIT_C26323",
      "http://purl.obolibrary.org/obo/NCIT_C35814",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C7065",
      "http://purl.obolibrary.org/obo/NCIT_C27134",
      "http://purl.obolibrary.org/obo/NCIT_C35813",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C9305",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C27910",
      "http://purl.obolibrary.org/obo/NCIT_C3181",
      "http://purl.obolibrary.org/obo/NCIT_C3483",
      "http://purl.obolibrary.org/obo/NCIT_C3161",
      "http://purl.obolibrary.org/obo/NCIT_C7539"
    ],
    "hasDirectChildren": true,
    "numDescendants": 3,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 3,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47530"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Felbamate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47530",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A propanediol compound with anticonvulsant and antiepileptic properties. Although the exact mechanism of action is unknown, Felbamate may be an antagonist at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate (NMDA) receptor-ionophore complex, thereby blocking the effects of the excitatory amino acids, suppressing neuronal firing, and preventing seizure activity. Felbamate also has weak inhibitory effects on gamma-aminobutyric acid (GABA) receptor binding sites which may contribute to its inhibitory effect on neuronal excitatory."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C264",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C264",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C264",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C264",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47531"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fenoldopam Mesylate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47531",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The mesylate salt form of fenoldopam, a benzazepine derivative with rapid-acting vasodilator activity. Fenoldopam mesylate is a racemic mixture of S- and R- isomers; the latter is responsible for the biological activity and has a significantly higher affinity for dopamine D1-like receptors (D1 and D5) as well as moderate affinity to alpha-2 adrenergic receptors. This agent selectively activates the dopamine D1-like receptor, thereby causing vasodilatation and increasing renal perfusion."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C66884",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C66884",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C66884",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C66884",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47532"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ferric Ferrocyanide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47532",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A chelating agent with strong binding affinity for thallium, cesium, and other ions. Ferric hexacyanoferrate is used for the treatment of acute and chronic thallium and cesium poisoning. This agent is not absorbed in the gastrointestinal tract and it chelates thallium or cesium ion in the intestines. The resulting complex is eliminated via the feces."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C360",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C360",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C360",
      "http://purl.obolibrary.org/obo/NCIT_C1932",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C360",
      "http://purl.obolibrary.org/obo/NCIT_C1932",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47533"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Flavoxate Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47533",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt form of flavoxate, a parasympatholytic agent with antispasmodic activity. Flavoxate hydrochloride competitively binds to muscarinic receptors, thereby preventing the actions of acetylcholine. This relaxes vascular smooth muscle, mainly of the urinary tract, and prevents smooth muscle contractions."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29704",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29704",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29704",
      "http://purl.obolibrary.org/obo/NCIT_C66880",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29704",
      "http://purl.obolibrary.org/obo/NCIT_C66880",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47534"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Flumazenil"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47534",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An imidazo-benzodiazepine derivative, effective in reversing benzodiazepine-induced activities. Flumazenil antagonizes the benzodiazepine binding site of the gamma-aminobutyric acid (GABA)/benzodiazepine receptor complex in the central nervous system (CNS), thereby preventing the chloride channel opening events and inhibiting neuronal hyperpolarization. As a result, flumazenil reverses benzodiazepine-induced effects including sedation, psychomotor deficits, amnesia, and hypoventilation in a dose-dependent manner."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1012",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1012",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1012",
      "http://purl.obolibrary.org/obo/NCIT_C28197",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C29756"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1012",
      "http://purl.obolibrary.org/obo/NCIT_C28197",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C29756"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47535"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fluorometholone Acetate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47535",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The acetate salt form of fluorometholone, a synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone acetate exerts its effect by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47536"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fluphenazine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47536",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A phenothiazine with antipsychotic activity. Fluphenazine exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. This prevents the actions of dopamine, thereby reducing the hallucinations and delusions that are associated with schizophrenia."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29710",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29710",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29710",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29710",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47537"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Flurandrenolide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47537",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Flurandrenolide exerts its effects by interacting with specific cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47538"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fomepizole"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47538",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A pyrazole with competitive alcohol dehydrogenase inhibitor activity. Fomepizole prevents the metabolism of ethylene glycol and methanol by alcohol dehydrogenase, thereby inhibiting the formation of their toxic metabolites, glycolate and oxalate (from ethylene glycol), and formic acid (from methanol). Fomepizole is indicated for use as an antidote in ethylene glycol and methanol poisoning. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C471",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C471",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47539"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fondaparinux Sodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47539",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt form of fondaparinux, a synthetic glucopyranoside with antithrombotic activity. Fondaparinux sodium selectively binds to antithrombin III, thereby potentiating the innate neutralization of activated factor X (Factor Xa) by antithrombin. Neutralization of Factor Xa inhibits its activity and interrupts the blood coagulation cascade, thereby preventing thrombin formation and thrombus development. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C263",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C263",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C263",
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C263",
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C4754"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Spindle Cell Hemangioma"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C4754",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A hemangioma characterized by the presence of spindle endothelial cells."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C3085",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C3085",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C3085",
      "http://purl.obolibrary.org/obo/NCIT_C8537",
      "http://purl.obolibrary.org/obo/NCIT_C7387",
      "http://purl.obolibrary.org/obo/NCIT_C7388",
      "http://purl.obolibrary.org/obo/NCIT_C35117",
      "http://purl.obolibrary.org/obo/NCIT_C2931",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C4784",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C7389",
      "http://purl.obolibrary.org/obo/NCIT_C53684",
      "http://purl.obolibrary.org/obo/NCIT_C3677",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C3085",
      "http://purl.obolibrary.org/obo/NCIT_C8537",
      "http://purl.obolibrary.org/obo/NCIT_C7387",
      "http://purl.obolibrary.org/obo/NCIT_C7388",
      "http://purl.obolibrary.org/obo/NCIT_C35117",
      "http://purl.obolibrary.org/obo/NCIT_C2931",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C4784",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C7389",
      "http://purl.obolibrary.org/obo/NCIT_C53684",
      "http://purl.obolibrary.org/obo/NCIT_C3677",
      "http://purl.obolibrary.org/obo/NCIT_C7062",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47540"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Formoterol Fumarate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47540",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The fumarate salt form of formoterol, a long-acting and selective sympathomimetic beta-receptor agonist with bronchodilator activity. Formoterol fumarate binds beta 2 adrenergic receptors in bronchial smooth muscle and stimulates intracellular adenyl cyclase, thereby increasing the production of cyclic adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, improve mucociliary clearance and reduce mediator substance release in inflammatory cells, especially from mast cells. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C319",
      "http://purl.obolibrary.org/obo/NCIT_C48149"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C319",
      "http://purl.obolibrary.org/obo/NCIT_C48149"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C319",
      "http://purl.obolibrary.org/obo/NCIT_C29712",
      "http://purl.obolibrary.org/obo/NCIT_C78273",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C48149",
      "http://purl.obolibrary.org/obo/NCIT_C87053",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C319",
      "http://purl.obolibrary.org/obo/NCIT_C29712",
      "http://purl.obolibrary.org/obo/NCIT_C78273",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C48149",
      "http://purl.obolibrary.org/obo/NCIT_C87053",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47541"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fosfomycin Tromethamine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47541",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The tromethamine salt form of fosfomycin, a synthetic broad-spectrum antibiotic. Fosfomycin tromethamine binds to and inactivates the enzyme enolpyruvyl transferase. This leads to an irreversible blockage of the condensation of uridine diphosphate-N-acetylglucosamine with p-enolpyruvate, which is one of the first steps of bacterial cell wall synthesis, thereby eventually causing cell lysis. In addition, fosfomycin tromethamine reduces the adherence of bacteria to uroepithelial cells. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C255",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C255",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C255",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C255",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47542"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fosinopril Sodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47542",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C247",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C247",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C247",
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C783",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C247",
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C783",
      "http://purl.obolibrary.org/obo/NCIT_C471"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47543"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Fosphenytoin Sodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47543",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt form of fosphenytoin, a prodrug that is hydrolyzed to the anticonvulsant phenytoin upon parental administration. Phenytoin exerts its effect most likely through an enhancement of sodium efflux from neurons in the motor cortex. This leads to a suppression of excessive neuronal firing and spread of seizure activity. Other physiologic effects from actions of phenytoin include modulation of the voltage-dependent calcium channels of neurons, inhibition of calcium flux across neuronal membranes and enhancement of sodium-potassium ATPase activity of neurons and glial cells. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C264",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C264",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C264",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C264",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47544"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Frovatriptan Succinate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47544",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C47794",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C47794",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47794",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47794",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47545"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Gadoversetamide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47545",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A paramagnetic extracellular magnetic resonance imaging (MRI) contrast agent that facilitates visualization of abnormal vascularity. When placed in a magnetic field, gadoversetamide decreases T1 (spin-lattice or longitudinal relaxation time) and T2 (spin-spin or transverse relaxation time) values in tissues where it accumulates. At the recommended dose, the effect is primarily on T1 relaxation time, and produces an increase in signal intensity. Gadoversetamide does not cross the intact blood-brain barrier. However, abnormal vascularity or disruption of the blood-brain barrier allows accumulation of gadoversetamide. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C62358",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C62358",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C62358",
      "http://purl.obolibrary.org/obo/NCIT_C360",
      "http://purl.obolibrary.org/obo/NCIT_C1932",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C62358",
      "http://purl.obolibrary.org/obo/NCIT_C360",
      "http://purl.obolibrary.org/obo/NCIT_C1932",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47546"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Galantamine Hydrobromide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47546",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrobromide salt form of galantamine, a tertiary alkaloid obtained synthetically or naturally from the bulbs and flowers of Narcissus and several other genera of the Amaryllidaceae family with anticholinesterase and neurocognitive-enhancing activities. Galantamine competitively and reversibly inhibits acetylcholinesterase, thereby increasing the concentration and enhancing the action of acetylcholine (Ach). In addition, galantamine is a ligand for nicotinic acetylcholine receptors, which may increase the presynaptic release of Ach and activate postsynaptic receptors. This agent may improve neurocognitive function in mild and moderate Alzheimer' s disease and may reduce abstinence-induced cognitive symptoms that promote smoking relapse."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C47792",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C47792",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47792",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47792",
      "http://purl.obolibrary.org/obo/NCIT_C471",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47547"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Gallium Citrate Ga-67"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47547",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The citrate salt of the radioisotope gallium Ga 67. Although the mechanism is unknown, gallium Ga 67 concentrates in lysosomes and is bound to a soluble intracellular protein in certain viable primary and metastatic tumors and focal sites of inflammation, allowing scintigraphic localization. Ga-67 scintigraphy (GS) cannot differentiate between tumor and acute inflammation."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1446",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1446",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47548"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Gemifloxacin Mesylate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47548",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The mesylate salt form of gemifloxacin, a synthetic broad-spectrum fluoroquinolone with antibacterial activity. Gemifloxacin mesylate inhibits activities of DNA gyrase and topoisomerase IV, thereby inhibiting DNA replication and eventually bacterial growth. This fluoroquinolone exerts an enhanced spectrum of activity against gram-positive bacteria such as Streptococcus pneumoniae and Staphylococcus aureus, in addition to its activity against gram-negative bacteria."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C795",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C795",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C795",
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C795",
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47549"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Gluconolactone"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47549",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A naturally occurring polyhydroxy acid (PHA) with metal chelating, moisturizing and antioxidant activity. Gluconolactone can be produced by enzymatic oxidation of D-glucose oxidation. Its ability in free radicals scavenging accounts for its antioxidant property. It is used in cosmetic product and as a coagulant in tofu processing. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C275",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C275",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C275",
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C275",
      "http://purl.obolibrary.org/obo/NCIT_C26170",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C4755"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Chondrogenic Neoplasm"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C4755",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A benign, intermediate, or malignant cartilaginous matrix-producing neoplasm.  Representative examples include osteochondroma, chondroblastoma, and chondrosarcoma."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C7059",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C7059",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C7059",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C7059",
      "http://purl.obolibrary.org/obo/NCIT_C3810",
      "http://purl.obolibrary.org/obo/NCIT_C27574",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C4741"
    ],
    "hasDirectChildren": true,
    "numDescendants": 75,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 75,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47550"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Guanfacine Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47550",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt form of guanfacine, a centrally acting alpha-2 adrenergic agonist with antihypertensive activity. Alpha-2 receptor stimulation by guanfacine hydrochloride results in a decreased sympathetic outflow from the vasomotor center to the heart, kidneys, and peripheral vasculature. This leads to a decrease in heart rate and peripheral vascular resistance. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C29709"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C29709"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C29709",
      "http://purl.obolibrary.org/obo/NCIT_C87053",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C270",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C29709",
      "http://purl.obolibrary.org/obo/NCIT_C87053",
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47551"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Guanidine Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47551",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt form of guanidine, a strong basic compound with parasympathomimetic activity. Guanidine hydrochloride enhances the release of acetylcholine following a nerve impulse and potentiates acetylcholine actions on muscarinic and nicotinic receptors. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C45678",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C45678",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47552"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Halcinonide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47552",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A topical, synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Halcinonide exerts its effect by interacting with specific intracellular receptors, and the ligand-receptor complex subsequently modulates gene expressions via the typical glucocorticoid signalling pathway. This results in the synthesis of certain anti-inflammatory proteins as well as in synthesis inhibition of certain inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are accomplished. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47553"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Halobetasol Propionate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47553",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The propionate salt form of halobetasol, a synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictor activities. Halobetasol, a topical steroid, diffuses across cell membranes to interact with cytoplasmic corticosteroid receptors located in both the dermal and intradermal cells, thereby activating gene expression of anti-inflammatory proteins mediated via corticosteroid receptor response element. Specifically, this agent induces phospholipase A2 inhibitory proteins, which inhibit the release of arachidonic acid, thereby inhibiting the biosynthesis of potent mediators of inflammation, such as prostaglandins and leukotrienes. As a result, halobetasol reduces edema, erythema, and pruritus through its cutaneous effects on vascular dilation and permeability."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C521",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C521",
      "http://purl.obolibrary.org/obo/NCIT_C211",
      "http://purl.obolibrary.org/obo/NCIT_C2364",
      "http://purl.obolibrary.org/obo/NCIT_C1636",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C574",
      "http://purl.obolibrary.org/obo/NCIT_C308"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47554"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Halothane"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47554",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A nonflammable, halogenated, hydrocarbon and general inhalation anesthetic. Although the exact mechanism of action is unknown, halothane provides relatively rapid induction of anesthesia by depressing the central nervous system, thereby producing a reversible loss of consciousness and sensation. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C245",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C245",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C245",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C245",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47555"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hetacillin"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47555",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A semi-synthetic penicillin compound with bactericidal properties. Hetacillin is a prodrug that is converted to ampicillin via esterases. Ampicillin binds to inactivated penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs, including transpeptidases, carboxypeptidases, and endopeptidases, participate in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. This results in the weakening of the bacterial cell wall and eventually causes cell lysis. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1500",
      "http://purl.obolibrary.org/obo/NCIT_C260",
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1500",
      "http://purl.obolibrary.org/obo/NCIT_C260",
      "http://purl.obolibrary.org/obo/NCIT_C258",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47556"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hexachlorophene"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47556",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A chlorinated bisphenol antiseptic agent with bacteriostatic activity. Hexachlorophene is used topically in soaps, creams and dermatological preparations and is active against gram-positive organisms, but much less effective against gram-negative organisms. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28394",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28394",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28394",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28394",
      "http://purl.obolibrary.org/obo/NCIT_C254",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47557"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hydroflumethiazide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47557",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An intermediate-acting benzothiadiazine sulfonamide derivative belonging to the class of the thiazide diuretics."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C49185",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C49185",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C49185",
      "http://purl.obolibrary.org/obo/NCIT_C448",
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C49185",
      "http://purl.obolibrary.org/obo/NCIT_C448",
      "http://purl.obolibrary.org/obo/NCIT_C78275",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47558"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hydroxyamphetamine Hydrobromide"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47558",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrobromide salt form of hydroxyamphetamine, an indirect-acting sympathomimetic amine with adrenergic properties. Hydroxyamphetamine, when applied topically to the eye, stimulates the release of norepinephrine from postganglionic adrenergic nerves resulting in the stimulation of both alpha and beta adrenergic receptors. Local alpha stimulatory effects include dilation of the pupil, increased flow of aqueous humor, and vasoconstriction; whereas beta stimulatory effects include relaxation of the ciliary muscle and a decreased production in aqueous humor."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29747",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29747",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29747",
      "http://purl.obolibrary.org/obo/NCIT_C78272",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47559"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hydroxyzine Hydrochloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47559",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The hydrochloride salt form of hydroxyzine, a piperazine histamine H1-receptor antagonist with anti-allergic, antispasmodic, sedative, anti-emetic and anti-anxiety properties. Hydroxyzine hydrochloride blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. In addition, hydroxyzine hydrochloride crosses the blood-brain barrier and acts on the histamine H1-receptors in the central nervous system. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29578",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29578",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29578",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29578",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C4756"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Vulvar Intraepithelial Neoplasia"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C4756",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Intraepithelial neoplasia of the vulvar squamous epithelium. There is no evidence of invasion. It includes vulvar squamous intraepithelial lesion, HPV-associated and vulvar intraepithelial neoplasia, HPV-independent."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C27788",
      "http://purl.obolibrary.org/obo/NCIT_C40283",
      "http://purl.obolibrary.org/obo/NCIT_C8334"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C27788",
      "http://purl.obolibrary.org/obo/NCIT_C40283",
      "http://purl.obolibrary.org/obo/NCIT_C8334"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C27788",
      "http://purl.obolibrary.org/obo/NCIT_C27020",
      "http://purl.obolibrary.org/obo/NCIT_C4875",
      "http://purl.obolibrary.org/obo/NCIT_C156660",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C7422",
      "http://purl.obolibrary.org/obo/NCIT_C3341",
      "http://purl.obolibrary.org/obo/NCIT_C8278",
      "http://purl.obolibrary.org/obo/NCIT_C40283",
      "http://purl.obolibrary.org/obo/NCIT_C3443",
      "http://purl.obolibrary.org/obo/NCIT_C27631",
      "http://purl.obolibrary.org/obo/NCIT_C3053",
      "http://purl.obolibrary.org/obo/NCIT_C3674",
      "http://purl.obolibrary.org/obo/NCIT_C156482",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C8334",
      "http://purl.obolibrary.org/obo/NCIT_C8366"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C27788",
      "http://purl.obolibrary.org/obo/NCIT_C27020",
      "http://purl.obolibrary.org/obo/NCIT_C4875",
      "http://purl.obolibrary.org/obo/NCIT_C156660",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C7422",
      "http://purl.obolibrary.org/obo/NCIT_C3341",
      "http://purl.obolibrary.org/obo/NCIT_C8278",
      "http://purl.obolibrary.org/obo/NCIT_C40283",
      "http://purl.obolibrary.org/obo/NCIT_C3443",
      "http://purl.obolibrary.org/obo/NCIT_C27631",
      "http://purl.obolibrary.org/obo/NCIT_C3053",
      "http://purl.obolibrary.org/obo/NCIT_C3674",
      "http://purl.obolibrary.org/obo/NCIT_C156482",
      "http://purl.obolibrary.org/obo/NCIT_C3263",
      "http://purl.obolibrary.org/obo/NCIT_C3262",
      "http://purl.obolibrary.org/obo/NCIT_C3792",
      "http://purl.obolibrary.org/obo/NCIT_C3709",
      "http://purl.obolibrary.org/obo/NCIT_C4741",
      "http://purl.obolibrary.org/obo/NCIT_C8334",
      "http://purl.obolibrary.org/obo/NCIT_C8366"
    ],
    "hasDirectChildren": true,
    "numDescendants": 6,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 6,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47560"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hydroxyzine Pamoate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47560",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The pamoate salt form of hydroxyzine, a synthetic piperazine histamine H1-receptor antagonist with anti-allergic, antispasmodic, sedative, anti-emetic and anti-anxiety properties. Hydroxyzine pamoate blocks the H1 histamine receptor and prevents the symptoms that are caused by histamine activity on capillaries, bronchial smooth muscle, and gastrointestinal smooth muscle, including vasodilatation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of gastrointestinal smooth muscle. In addition, hydroxyzine pamoate crosses the blood-brain barrier and acts on the histamine H1-receptors in the central nervous system. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C29578",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C29578",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29578",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C29578",
      "http://purl.obolibrary.org/obo/NCIT_C308",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47561"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ibutilide Fumarate"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47561",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The fumarate salt form of ibutilide, a class III antiarrhythmic agent. Ibutilide exerts its effect by activating a slow, inward, predominately sodium current rather than by blocking outward potassium currents. This results in prolongation of atrial and ventricular action potential duration and refractory periods. Ibutilide slightly decreases the sinus rate and atrioventricular (AV) conduction and produces a dose-related prolongation of the QT interval. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/NCIT_C47793",
      "http://purl.obolibrary.org/obo/NCIT_C93038"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/NCIT_C47793",
      "http://purl.obolibrary.org/obo/NCIT_C93038"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47793",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C93038"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C47793",
      "http://purl.obolibrary.org/obo/NCIT_C78274",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908",
      "http://purl.obolibrary.org/obo/NCIT_C93038"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47562"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Indium In-111 Chloride"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47562",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A radioactive salt that is used as a reagent in the preparation of indium 111-labeled radiopharmaceuticals. Indium 111-labeled radioconjugates are used as radioactive tracers in nuclear medicine that detect malignant lesions and inflammatory tissues probably due to an increased capillary permeability. Indium-111 chloride is particularly used in the radiolabeling of the monoclonal antibodies satumomab pendetide, 7E11-C5.3 (CYT-356), and ibritumomab tiuxetan. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C1446",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C1446",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47563"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Insulin Aspart"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47563",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C581",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C581",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C581",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C581",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47564"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Insulin Glargine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47564",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin glargine inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin glargine also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C581",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C581",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C581",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C581",
      "http://purl.obolibrary.org/obo/NCIT_C548",
      "http://purl.obolibrary.org/obo/NCIT_C147908",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47565"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iobenguane Sulfate I-131"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47565",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sulfate salt form of iobenguane, an iodine-131 labeled aralkylguanidine norepinephrine analogue used as a diagnostic imaging tracer. Iobenguane is structurally related to guanethidine and norepinephrine. This agent, functioning as a false substrate of norepinephrine, is taken up and localized in the granules of pre-synaptic adrenergic neurons, thus making this compound useful for the imaging of neuroendocrine tissues and tumors."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47566"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iodipamide Meglumine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47566",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The meglumine salt form of iodipamide, a tri-iodinated benzoate derivative and an ionic dimeric contrast agent used in diagnostic imaging. When administered in vivo, iodipamide is removed from the liver and secreted into the biliary tract. Like other organic iodine compounds, this agent blocks x-ray and appears opaque on x-ray film; thereby it enhances the visibility of the bile ducts and gallbladder during cholangiography and cholecystography procedures."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47567"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iopamidol"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47567",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "An organic iodine compound and used as a non-ionic water soluble radiographic contrast medium. Iopamidol blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by iopamidol is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of iopamidol. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47568"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iothalamate Meglumine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47568",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The meglumine salt form of iothalamate, an organic iodine compound and a radiographic contrast medium. Iothalamate meglumine blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by iothalamate meglumine is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of iothalamate meglumine. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47569"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iothalamate Sodium"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47569",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt form of iothalamate, an organic iodine compound and a radiographic contrast medium. Iothalamate sodium blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by iothalamate sodium is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of iothalamate sodium. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C4757"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Hypertensive Nephropathy"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C4757",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "Kidney damage that results from chronically elevated blood pressure; complications include glomerular damage resulting in proteinuria and hematuria."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C34843",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C34843",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C34843",
      "http://purl.obolibrary.org/obo/NCIT_C27600",
      "http://purl.obolibrary.org/obo/NCIT_C27599",
      "http://purl.obolibrary.org/obo/NCIT_C156664",
      "http://purl.obolibrary.org/obo/NCIT_C156660",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C53531",
      "http://purl.obolibrary.org/obo/NCIT_C53529",
      "http://purl.obolibrary.org/obo/NCIT_C3430",
      "http://purl.obolibrary.org/obo/NCIT_C3149"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C34843",
      "http://purl.obolibrary.org/obo/NCIT_C27600",
      "http://purl.obolibrary.org/obo/NCIT_C27599",
      "http://purl.obolibrary.org/obo/NCIT_C156664",
      "http://purl.obolibrary.org/obo/NCIT_C156660",
      "http://purl.obolibrary.org/obo/NCIT_C27551",
      "http://purl.obolibrary.org/obo/NCIT_C2991",
      "http://purl.obolibrary.org/obo/NCIT_C7057",
      "http://purl.obolibrary.org/obo/NCIT_C53531",
      "http://purl.obolibrary.org/obo/NCIT_C53529",
      "http://purl.obolibrary.org/obo/NCIT_C3430",
      "http://purl.obolibrary.org/obo/NCIT_C3149"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47570"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Iothalamate Sodium I-125"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47570",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The sodium salt form of iothalamate, an organic iodine compound, labeled with iodine I-125 and used as a radiopharmaceutical. Iothalamate sodium I-125 is cleared by glomerular filtration without tubular secretion or reabsorption and can be used as a diagnostic tool to determine the glomerular filtration rate."
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C2124",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C2124",
      "http://purl.obolibrary.org/obo/NCIT_C1446",
      "http://purl.obolibrary.org/obo/NCIT_C1909",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "NCIT:C47571"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Ioxaglate Meglumine"
    },
    "iri": "http://purl.obolibrary.org/obo/NCIT_C47571",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "reification"
      ],
      "value": {
        "type": [
          "literal"
        ],
        "value": "The meglumine salt form of ioxaglate, an organic iodine compound and a radiographic contrast medium. Ioxaglate meglumine blocks x-rays as they pass through the body, thereby allowing body structures not containing iodine to be visualized. The degree of opacity produced by ioxaglate meglumine is directly proportional to the total amount of the iodinated contrast agent in the path of the x-rays. The visualization of body structures is dependent upon the distribution and elimination of ioxaglate meglumine. (NCI05)"
      },
      "axioms": [
        {
          "http://purl.obolibrary.org/obo/NCIT_P378": {
            "type": [
              "literal"
            ],
            "value": "NCI"
          }
        }
      ]
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/NCIT_C28500",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/NCIT_C28500",
      "http://purl.obolibrary.org/obo/NCIT_C390",
      "http://purl.obolibrary.org/obo/NCIT_C1966",
      "http://purl.obolibrary.org/obo/NCIT_C802",
      "http://purl.obolibrary.org/obo/NCIT_C45678",
      "http://purl.obolibrary.org/obo/NCIT_C1908"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]